China
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.07 B
|
Dec. 31, 2023 | USD 1.35 | NA |
|
China |
|
2 |
USD 551.46 M
|
Dec. 31, 2023 | USD 1.84 | NA |
|
China |
|
3 |
USD 434.90 M
|
Dec. 31, 2023 | USD 0.81 | NA |
|
China |
|
4 |
USD 423.87 M
|
Dec. 31, 2023 | USD 3.75 | NA |
|
China |
|
5 |
USD 364.42 M
|
Dec. 31, 2023 | USD 4.24 | NA |
|
China |
|
6 |
USD 327.29 M
|
Dec. 31, 2023 | USD 0.25 | NA |
|
China |
|
7 |
USD 296.09 M
|
Dec. 31, 2023 | USD 1.80 | NA |
|
China |
|
8 |
USD 225.54 M
|
Dec. 31, 2023 | USD 14.52 | NA |
|
China |
|
9 |
USD 212.59 M
|
Dec. 31, 2023 | USD 9.07 | NA |
|
China |
|
10 |
USD 150.12 M
|
Dec. 31, 2023 | USD 2.21 | NA |
|
China |
|
11 |
USD 146.53 M
|
Dec. 31, 2023 | USD 1.90 | NA |
|
China |
|
12 |
USD 137.79 M
|
Dec. 31, 2023 | USD 1.76 | NA |
|
China |
|
13 |
USD 135.34 M
|
Dec. 31, 2023 | USD 7.68 | NA |
|
China |
|
14 |
USD 134.15 M
|
Dec. 31, 2023 | USD 1.15 | NA |
|
China |
|
15 |
USD 124.16 M
|
Dec. 31, 2023 | USD 0.39 | NA |
|
China |
|
16 |
USD 118.56 M
|
Dec. 31, 2023 | USD 1.46 | NA |
|
China |
|
17 |
USD 107.85 M
|
Dec. 31, 2023 | USD 1.51 | NA |
|
China |
|
18 |
USD 106.30 M
|
Dec. 31, 2023 | USD 6.08 | NA |
|
China |
|
19 |
USD 102.09 M
|
Dec. 31, 2023 | USD 0.33 | NA |
|
China |
|
20 |
USD 100.03 M
|
Dec. 31, 2023 | USD 1.57 | NA |
|
China |
|
21 |
USD 98.75 M
|
Dec. 31, 2023 | USD 0.76 | NA |
|
China |
|
22 |
USD 95.92 M
|
Dec. 31, 2023 | USD 1.45 | NA |
|
China |
|
23 |
USD 89.00 M
|
Dec. 31, 2023 | USD 6.71 | NA |
|
China |
|
24 |
USD 85.66 M
|
Dec. 31, 2023 | USD 7.82 | NA |
|
China |
|
25 |
USD 69.89 M
|
Dec. 31, 2023 | USD 4.84 | NA |
|
China |
|
26 |
USD 68.22 M
|
Dec. 31, 2023 | USD 1.31 | NA |
|
China |
|
27 |
USD 66.19 M
|
Dec. 31, 2023 | USD 1.17 | NA |
|
China |
|
28 |
USD 63.44 M
|
Dec. 31, 2023 | USD 6.10 | NA |
|
China |
|
29 |
USD 62.67 M
|
Dec. 31, 2023 | USD 2.15 | NA |
|
China |
|
30 |
USD 58.77 M
|
Dec. 31, 2023 | USD 2.24 | NA |
|
China |
|
31 |
USD 57.64 M
|
Dec. 31, 2023 | USD 5.28 | NA |
|
China |
|
32 |
USD 54.70 M
|
Dec. 31, 2023 | USD 0.30 | NA |
|
China |
|
33 |
USD 53.89 M
|
Dec. 31, 2023 | USD 2.34 | NA |
|
China |
|
34 |
USD 53.68 M
|
Dec. 31, 2023 | USD 0.69 | NA |
|
China |
|
35 |
USD 51.94 M
|
Dec. 31, 2023 | USD 4.49 | NA |
|
China |
|
36 |
USD 51.26 M
|
Dec. 31, 2023 | USD 1.44 | NA |
|
China |
|
37 |
USD 51.18 M
|
Dec. 31, 2023 | USD 2.39 | NA |
|
China |
|
38 |
USD 51.00 M
|
Dec. 31, 2023 | USD 0.75 | NA |
|
China |
|
39 |
USD 50.86 M
|
Dec. 31, 2023 | USD 0.15 | NA |
|
China |
|
40 |
USD 49.26 M
|
Dec. 31, 2023 | USD 4.55 | NA |
|
China |
|
41 |
USD 47.56 M
|
Dec. 31, 2023 | USD 1.77 | NA |
|
China |
|
42 |
USD 46.63 M
|
Dec. 31, 2023 | USD 0.66 | NA |
|
China |
|
43 |
USD 46.21 M
|
Dec. 31, 2023 | USD 4.40 | NA |
|
China |
|
44 |
USD 41.01 M
|
Dec. 31, 2023 | USD 1.90 | NA |
|
China |
|
45 |
USD 40.80 M
|
Dec. 31, 2023 | USD 1.68 | NA |
|
China |
|
46 |
USD 38.94 M
|
Dec. 31, 2023 | USD 0.64 | NA |
|
China |
|
47 |
USD 38.69 M
|
Dec. 31, 2023 | USD 0.50 | NA |
|
China |
|
48 |
USD 38.67 M
|
Dec. 31, 2023 | USD 0.41 | NA |
|
China |
|
49 |
USD 35.56 M
|
Dec. 31, 2023 | USD 0.71 | NA |
|
China |
|
50 |
USD 35.18 M
|
Dec. 31, 2023 | USD 2.78 | NA |
|
China |
The Healthcare company in China with the highest Net Cash Used Provided By Financing Activities is Genscript Biotech Corporation (HKSE: 1548.HK) at USD 1.07 B.
The Healthcare company in China with the lowest Net Cash Used Provided By Financing Activities is Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Shenzhen Stock Exchange: 300760.SZ) at USD -1.52 B.
The top 10 Healthcare companies in China by Net Cash Used Provided By Financing Activities are Genscript Biotech Corporation, Pharmaron Beijing Co., Ltd., MicroPort Scientific Corporation, Intco Medical Technology Co., Ltd., Innovent Biologics, Inc., Inner Mongolia Baotou Steel Union Co., Ltd., Zhejiang Jiuzhou Pharmaceutical Co., Ltd, Shanghai MicroPort Endovascular MedTech Co., Ltd., Suzhou Zelgen Biopharmaceuticals Co., Ltd. and Shinva Medical Instrument Co., Ltd..
The bottom 10 Healthcare companies in China by Net Cash Used Provided By Financing Activities are Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Sinopharm Group Co. Ltd., Chongqing Zhifei Biological Products Co., Ltd., WuXi AppTec Co., Ltd., Genertec Universal Medical Group Company Limited, Jiangsu Hengrui Medicine Co., Ltd., Yunnan Baiyao Group Co.,Ltd, Dian Diagnostics Group Co.,Ltd., LBX Pharmacy Chain Joint Stock Company and China National Accord Medicines Corporation Ltd..